Citizens Reiterates Market Outperform on Biomea Fusion, Maintains $7 Price Target

Benzinga · 3d ago
Citizens analyst Jonathan Wolleben reiterates Biomea Fusion (NASDAQ:BMEA) with a Market Outperform and maintains $7 price target.